---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-23-000094"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2023-09-15T23:59:59+00:00"
generated_at: "2026-06-10T16:13:48.237007+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# BRTX stockholders elect directors, approve share increase, ratify auditor at annual meeting

## Summary
- Class III directors Lance Alstodt and Patrick F. Williams elected with 864,671 and 662,099 votes for, respectively.
- Amendment to 2021 Stock Incentive Plan approved: 571,623 for, 276,247 against, 1,907,427 broker non-votes.
- Marcum LLP ratified as independent auditor for FY 2023: 2,751,541 for, 15,525 against.
- Plan amendment increases authorized shares from 2.5M to 3.85M.
- All proposals passed despite significant broker non-votes on director election and plan.

## SEC filing metadata
- accession: 0001021771-23-000094
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2023-09-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/0001021771-23-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/brt8kdtd091323.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-23-000094
- JSON: https://secwatch.observer/filing/0001021771-23-000094.json
- Plain text: https://secwatch.observer/filing/0001021771-23-000094.txt

## Key facts
- Shareholder Votes
  BioRestorative Therapies, Inc. shareholders approved Election of Class III Directors at the 2023-09-13 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-09-13
  source text: Number of Shares For Withheld Broker Non-Votes Lance Alstodt 864,671 6,038 1,907,427 Patrick F. Williams 662,099 208,610 1,907,427
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/0001021771-23-000094-index.htm
- Shareholder Votes
  BioRestorative Therapies, Inc. shareholders approved Ratification of the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-09-13 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-09-13
  source text: For 2,751,541 Against 15,525 Abstentions 11,070
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/0001021771-23-000094-index.htm
- Shareholder Votes
  BioRestorative Therapies, Inc. shareholders approved Approval of amendment to the Company’s 2021 Stock Incentive Plan to increase authorized shares from 2,500,000 to 3,850,000 at the 2023-09-13 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-09-13
  source text: Against 276,247 Abstentions 22,839
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177123000094/0001021771-23-000094-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.